Underwriters over-allotment is an additional 686,250 shares.
Net proceeds of ~$4.4M will be used for working capital and general corporate purposes.
Closing date is April 11.
Shares are down 23% premarket.
Previously: Daré Bio launches equity offering; shares down 19% after hours (April 8)
Subscribe for full text news in your inbox